Merrimack Pharmaceuticals, Inc. Stock price
Equities
MACK
US5903282094
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.75 USD | +0.20% | +0.41% | +9.99% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 192M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | -1M | EV / Sales 2022 | - |
Net cash position 2022 | 19.44M | Net cash position 2023 | 18.88M | EV / Sales 2023 | - |
P/E ratio 2022 |
-100
x | P/E ratio 2023 |
-162
x | Employees | 27 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.79% |
1 day | +0.20% | ||
1 week | +0.41% | ||
Current month | +0.34% | ||
1 month | +0.27% | ||
3 months | +10.90% | ||
6 months | +17.81% | ||
Current year | +9.99% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 92-12-31 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 03-12-31 |
Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 03-12-31 |
Director/Board Member | 45 | 19-09-18 | |
Ulrik Nielsen
FOU | Founder | 52 | 92-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.50% | 4 M€ | -5.15% | - | |
0.00% | 36 M€ | +4.74% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 14.75 | +0.20% | 129,206 |
24-03-26 | 14.72 | -0.07% | 103,473 |
24-03-25 | 14.73 | -0.41% | 99,675 |
24-03-22 | 14.79 | +0.68% | 193,562 |
24-03-21 | 14.69 | 0.00% | 90,378 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+9.99% | 214M | |
+9.16% | 45.97B | |
+53.75% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |